Keywords: euro, otc, pain, relief, market, led, intl
Euro OTC Pain Relief Market Led By Intl Brands
Article | 27 January 1997
Europe's non-prescription-bound pain relief market was worth $1.9billion at manufacturers' prices in 1996 and grew 37% from 1990 to last year, but its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
